BridgeMD
New treatment option for Dumping Syndrome
Official title Continuous Glucose Monitoring With iCan i3 in Post-Bariatric Patients With Late Dumping Syndrome
ClinicalTrials.gov ID: NCT07440706
What this study is testing
- What it's testing
- Late dumping syndrome is a common complication following Roux-en-Y gastric bypass, characterized by postprandial hypoglycemia with significant impact on patient safety and quality of life. Traditional capillary glucose monitoring has limited ability to detect rapid glycemic fluctuations.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Age 18-65 years
- History of Roux-en-Y gastric bypass ≥12 months
- Clinical diagnosis of late dumping syndrome
- Stable body weight (\<5% variation in last 3 months)
- Ability to provide informed consent
You likely can't join if
- Diagnosis of diabetes mellitus under treatment
- Use of antidiabetic medications (except acarbose)
- Pregnancy or breastfeeding
- Cognitive impairment affecting study participation
- Known hypersensitivity to CGM adhesives
- Conditions increasing risk of hypoglycemia (e.g., prolonged fasting)
See the full eligibility criteria
- Age 18-65 years
- History of Roux-en-Y gastric bypass ≥12 months
- Clinical diagnosis of late dumping syndrome
- Stable body weight (\<5% variation in last 3 months)
- Ability to provide informed consent
- Diagnosis of diabetes mellitus under treatment
- Use of antidiabetic medications (except acarbose)
- Pregnancy or breastfeeding
- Cognitive impairment affecting study participation
- Known hypersensitivity to CGM adhesives
- Conditions increasing risk of hypoglycemia (e.g., prolonged fasting)
- Active or prior malignancy
- Need for imaging procedures during study period
The study team makes the final eligibility decision.
Where it's taking place
- São José do Rio Preto, São Paulo, Brazil
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include São José do Rio Preto, São Paulo, Brazil. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.